1. Home
  2. RECT vs CUE Comparison

RECT vs CUE Comparison

Compare RECT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

HOLD

Current Price

$1.36

Market Cap

17.3M

Sector

N/A

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.56

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
CUE
Founded
1997
2014
Country
Singapore
United States
Employees
111
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
17.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RECT
CUE
Price
$1.36
$0.56
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
5.3M
21.7M
Earning Date
03-20-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
N/A
$27,466,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.74
N/A
Revenue Growth
N/A
195.75
52 Week Low
$1.00
$0.17
52 Week High
$4.98
$1.03

Technical Indicators

Market Signals
Indicator
RECT
CUE
Relative Strength Index (RSI) 47.69 57.32
Support Level $1.20 $0.24
Resistance Level $2.00 $0.84
Average True Range (ATR) 0.31 0.16
MACD -0.00 0.02
Stochastic Oscillator 18.42 57.41

Price Performance

Historical Comparison
RECT
CUE

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: